Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2) and (#3 or #4)
Latest & greatest articles for hypertension
The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on hypertension or other clinical topics then use Trip today.
This page lists the very latest high quality evidence on hypertension and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.
What is Trip?
Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.
Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.
As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.
For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via email@example.com
- to 30-minute intervals during the day and night. BP values considered high* = mean awake SBP =135 mmHg or DBP =85 mmHg or mean 24-hour SBP =130 mmHg or DBP =80 mmHg (Grade C) Preferred out-of-office methods for diagnosis HBPM Home bloodpressure monitoring is a self-monitoring method, which requires the patient to measure their BP twice in the morning and evening for 7 days. BP values considered high* = SBP =135 mmHg or DBP =85 mmHg (Grade C) Hypertension Canada 2020 guidelines measurement (...) of Cardiology 2 or on Hyperten- sion Canada’s website (www.hypertension.ca). What’s new Terminology Automated office bloodpressure (AOBP) is still the preferred method of measurement for measuring bloodpressure (BP) in the office. Where this method is not possible, office BP measurement (OBPM, previously known as non-AOBP) is suggested. Table 1 outlines the definitions and preferred meth- ods of BP measurement according to the 2020 Hypertension Canada guidelines. Home BP monitoring (HBPM) is recom- mended
to, *:First line drugs, ^: Not on QH List of approved medicines (LAM), ": Second line drugsQueensland Clinical Guideline: Hypertensivedisorders of pregnancy Refer to online version, destroy printed copies after use Page 5 of 32 Abbreviations ACE Angiotensin Converting Enzyme AFI Amniotic fluid index APLS Antiphospholipid syndrome BMI Body Mass Index BPBloodpressure CI Confidence Interval CMACE Centre for Maternal and Child Enquiries CTG Cardiotocograph dBP Diastolic bloodpressure DIC Disseminated (...) intravascular coagulation DVP Deepest vertical pocket FBC Full blood count FHR Fetal heart rate GA General anaesthesia HDP Hypertensivedisorders of pregnancy GP General Practitioner HELLP Haemolysis, Elevated Liver enzymes and Low Platelet count IUGR/FGR Intrauterine growth restriction/Fetal growth restriction LAM List of approved medicines LDH Lactate dehydrogenase LFT Liver function test sBP Systolic bloodpressure SLE Systemic lupus erythematosus RR Relative risk SpO 2 Saturation of peripheral oxygen
.-H.Y.). PMID: 33019798 DOI: Item in Clipboard Full-text links Cite Display options Display options Format Abstract Background: Masked hypertension is associated with adverse cardiovascular outcomes. Nonetheless, no randomized controlled trials exist in the treatment of masked hypertension. The aim of this randomized, placebo-controlled trial was to investigate the efficacy and safety of bloodpressure (BP)-lowering treatment with a Chinese herbal formula, gastrodia-uncaria granules, in patients (...) with masked hypertension. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: . Keywords: bloodpressure monitoring, ambulatory; masked hypertension; medicine, traditional Chinese; randomized controlled trial. Similar articles Wei FF, Li Y, Zhang L, Shan XL, Cheng YB, Wang JG, Yang CH, Staessen JA. Wei FF, et al. Am J Hypertens. 2016 Mar;29(3):326-31. doi: 10.1093/ajh/hpv106. Epub 2015 Jul 6. Am J Hypertens. 2016. PMID: 26150543 Clinical Trial. Shimada K, Ogihara T, Saruta T, Kuramoto K
pressure; however, many children identified as having elevatedbloodpressure will not have hypertension. One study was done in a hypertension clinic in Greece, possibly limiting generalizability to a primary care population in the United States. The other study took place in a high school clinic . Association With Adult Hypertension and Cardiovascular Disease Ten longitudinal studies provided evidence on the association between elevatedbloodpressure in childhood and adulthood (7 studies), carotid (...) and that the balance of benefits and harms cannot be determined. How Does Evidence Fit With Biological Understanding? The proportion of children with primary hypertension who revert to normal bloodpressure over time, without any intervention, and those who will continue to have hypertension in adulthood is unknown. Persistent elevation of bloodpressure in adults is an established risk factor for cardiovascular and cerebrovascular disorders and renal impairment. However, these conditions are often distant future
Diagnosis of hypertension using ambulatory bloodpressure monitoring in patients with clinic bloodpressure ? 140/90mmHg and ? 180/110mmHg 1 Public Summary Document Application No. 1572 – Diagnosis of hypertension using ambulatory bloodpressure monitoring in patients with clinic bloodpressure = 140/90mmHg and = 180/110mmHg Applicant: HighBloodPressure Research Council of Australia Inc. Date of MSAC consideration: MSAC 78 th Meeting, 3 April 2020 Context for decision: MSAC makes its advice (...) to comparative safety, clinical effectiveness and cost-effectiveness, MSAC supported MBS funding of diagnosis of hypertension using ambulatory bloodpressure monitoring (ABPM) in patients with clinic bloodpressure =140/90 mmHg and =180/110 mmHg on the basis that ABPM is the accepted gold standard for the diagnosis of highbloodpressure in primary care. MSAC accepted that ABPM was cost-effective, but advised that the proposed fee should not include the cost of the consumables. MSAC was concerned
in bloodpressure during treatment, manage hypertension with antihypertensives and if necessary, consider treatment interruption and subsequent adjustment of the niraparib dose as advised in discontinue niraparib in case of hypertensive crisis or if medically significant hypertension cannot be adequately controlled with antihypertensive therapy in cases of PRES, discontinue niraparib and treat specific symptoms including hypertension report any suspected adverse drug reactions associated with niraparib (...) cookies. You can at any time. Hide Show or hide search Search on GOV.UK Search National restrictions in England from 5 November Take action now for new rules in 2021 Niraparib (Zejula▼): reports of severe hypertension and posterior reversible encephalopathy syndrome (PRES), particularly in early treatment Increase the frequency of bloodpressure monitoring to at least weekly for the first 2 months, and then monitor monthly for the first year and periodically thereafter during treatment, following
for cardiovascular morbidity and mortality. Rigorously designed RCTs that carry out longer follow-up and address patient-important outcomes remain warranted. Trial registration PROSPERO Registration number: . Background Hypertension is one of the most prevalent conditions in the world and is commonly regarded as one of the main contributors to cardiovascular morbidity [ ] . Highbloodpressure (HBP) affects over 1.39 billion people around the world and could lead to an estimated 9.4 million deaths per year (...) randomized controlled trials (RCTs) reported in English or Chinese assessing EB for hypertension. (2) Type of participant: Patients with the following definition of HBP were included [ , ]: systolic bloodpressure (SBP) ≥140 mm Hg or diastolic bloodpressure (DBP) ≥90 mm Hg; or a previous physician diagnosis of hypertension. We placed no restrictions on age, sex, race, or duration of hypertension. (3) Types of intervention: EB alone or EB combined with either routine treatment (like antihypertensive
. Results: We analyzed data from 2113 trial participants with hypertension and diabetes mellitus who had the equivalent of ≥30 mg/day of urinary albumin excretion. Inhibitors of the renin-angiotensin system were more effective than calcium channel blockers in decreasing albuminuria (standardized difference in means -0.442; confidence interval, -0.660 to -0.225; P < .001). This finding was independent of the bloodpressure response to treatment. There was no difference between the 2 drug classes (...) Hypertens. 2004 May;13(3):319-24. doi: 10.1097/00041552-200405000-00009. Curr Opin Nephrol Hypertens. 2004. PMID: 15073491 Review. Fici F, Ari Bakir E, Ilkay Yüce E, Kanuncu S, Makel W, Tarim BA, Robles NR. Fici F, et al. HighBlood Press Cardiovasc Prev. 2020 Feb;27(1):43-49. doi: 10.1007/s40292-020-00358-1. Epub 2020 Jan 9. HighBlood Press Cardiovasc Prev. 2020. PMID: 31916208 Chaturvedi S, Lipszyc DH, Licht C, Craig JC, Parekh RS. Chaturvedi S, et al. Evid Based Child Health. 2014 Sep;9(3):581-3
biopsy remains the reference standard for the assessment and diagnosis of cirrhosis, hepatic vein catheterization with measurement of the hepatic venous pressure gradient (HVPG) is currently the benchmark technique for determining portal pressure. The HVPG quantifies the degree of portal hypertension due to sinusoidal resistance to blood flow. The HVPG is calculated as the difference between the wedged hepatic venous pressure and the free hepatic venous pressure. A normal HVPG is between 1 and 5 mmHg (...) ; Bill S. Majdalany, MD c ; Charles Y. Kim, MD d ; Osmanuddin Ahmed, MD e ; Sumeet K. Asrani, MD, MSc f ; Brooks D. Cash, MD g ; Jens Eldrup-Jorgensen, MD h ; A. Tuba Kendi, MD i ; Matthew J. Scheidt, MD j ; David M. Sella, MD k ; Karin E. Dill, MD l ; Eric J. Hohenwalter, MD. m Summary of Literature Review Introduction/Background Portal hypertension is a common clinical syndrome, hemodynamically defined by a pathological increase of the portal pressure and by the formation of portal-systemic
Alcohol intake reduction for controlling hypertension. Highbloodpressure constitutes one of the leading causes of mortality and morbidity all over the world. At the same time, heavy drinking increases the risk for developing cardiovascular diseases, including cardiomyopathy, hypertension, atrial arrhythmias, or stroke. Several studies have already assessed specifically the relationship between alcohol intake and hypertension. However, the potential effect on bloodpressure of alcohol intake (...) reduction interventions is largely unknown.To assess the effect of any intervention to reduce alcohol intake in terms of bloodpressure decrease in hypertensive people with alcohol consumption compared to a control intervention or no intervention at all. To determine additional effects related to mortality, major cardiovascular events, serious adverse events, or quality of life.The Cochrane Hypertension Information Specialist searched the following databases for randomised controlled trials up to June
, irbesartan, losartan potassium, olmesartan medoxomil, telmisartan, valsartan) in at least 1 arm. Of 763 RCTs identified, 77 met the eligibility criteria; of which, 37 reported mean change in systolic bloodpressure (SBP) and diastolic bloodpressure (DBP) from baseline in the office setting and were used to construct the network. A fixed-effects model (FEM) showed the effect of each drug vs. the reference, azilsartan. Using the FEM, the mean (95% credible interval) change from baseline in SBP/DBP (...) Comparative Effectiveness of Angiotensin II Receptor Blockers in Patients With Hypertension in Japan ― Systematic Review and Network Meta-Analysis ― Comparative Effectiveness of Angiotensin II Receptor Blockers in Patients With Hypertension in Japan ― Systematic Review and Network Meta-Analysis ― Toggle navigation Circulation Reports Online ISSN : 2434-0790 / / / Article overview Hypertension and Circulatory Control Comparative Effectiveness of Angiotensin II Receptor Blockers in Patients
5 classes of antihypertensive drugs were not linked to positive COVID-19 test results or severe COVID-19. Reynolds HR, Adhikari S, Pulgarin C, et al. Renin-angiotensin-aldosterone system inhibitors and risk of Covid-19. N Engl J Med. 2020;382:2441-8. 32356628.